Synthetic Biology-Europe Market Status and Trend Report 2013-2023
Report Summary
Synthetic Biology-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Synthetic Biology industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Synthetic Biology 2013-2017, and development forecast 2018-2023
Main market players of Synthetic Biology in Europe, with company and product introduction, position in the Synthetic Biology market
Market status and development trend of Synthetic Biology by types and applications
Cost and profit status of Synthetic Biology, and marketing status
Market growth drivers and challenges
The report segments the Europe Synthetic Biology market as:
Europe Synthetic Biology Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Synthetic Biology Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Xeno-nucleic Acids
Oligonucleotides
Chassis Organisms
Enzymes
Cloning and Assembly Kits
Europe Synthetic Biology Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Environmental Application
Medical Application
Industrial Application
Europe Synthetic Biology Market: Players Segment Analysis (Company and Product introduction, Synthetic Biology Sales Volume, Revenue, Price and Gross Margin):
Amyris
DuPont
GenScript USA
Intrexon
Integrated DNA Technologies
New England Biolabs
Novozymes
Royal DSM
Synthetic Genomics
Thermo Fisher Scientific
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Synthetic Biology-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Synthetic Biology industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Synthetic Biology 2013-2017, and development forecast 2018-2023
Main market players of Synthetic Biology in Europe, with company and product introduction, position in the Synthetic Biology market
Market status and development trend of Synthetic Biology by types and applications
Cost and profit status of Synthetic Biology, and marketing status
Market growth drivers and challenges
The report segments the Europe Synthetic Biology market as:
Europe Synthetic Biology Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Synthetic Biology Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Xeno-nucleic Acids
Oligonucleotides
Chassis Organisms
Enzymes
Cloning and Assembly Kits
Europe Synthetic Biology Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Environmental Application
Medical Application
Industrial Application
Europe Synthetic Biology Market: Players Segment Analysis (Company and Product introduction, Synthetic Biology Sales Volume, Revenue, Price and Gross Margin):
Amyris
DuPont
GenScript USA
Intrexon
Integrated DNA Technologies
New England Biolabs
Novozymes
Royal DSM
Synthetic Genomics
Thermo Fisher Scientific
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF SYNTHETIC BIOLOGY
1.1 Definition of Synthetic Biology in This Report
1.2 Commercial Types of Synthetic Biology
1.2.1 Xeno-nucleic Acids
1.2.2 Oligonucleotides
1.2.3 Chassis Organisms
1.2.4 Enzymes
1.2.5 Cloning and Assembly Kits
1.3 Downstream Application of Synthetic Biology
1.3.1 Environmental Application
1.3.2 Medical Application
1.3.3 Industrial Application
1.4 Development History of Synthetic Biology
1.5 Market Status and Trend of Synthetic Biology 2013-2023
1.5.1 Europe Synthetic Biology Market Status and Trend 2013-2023
1.5.2 Regional Synthetic Biology Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Synthetic Biology in Europe 2013-2017
2.2 Consumption Market of Synthetic Biology in Europe by Regions
2.2.1 Consumption Volume of Synthetic Biology in Europe by Regions
2.2.2 Revenue of Synthetic Biology in Europe by Regions
2.3 Market Analysis of Synthetic Biology in Europe by Regions
2.3.1 Market Analysis of Synthetic Biology in Germany 2013-2017
2.3.2 Market Analysis of Synthetic Biology in United Kingdom 2013-2017
2.3.3 Market Analysis of Synthetic Biology in France 2013-2017
2.3.4 Market Analysis of Synthetic Biology in Italy 2013-2017
2.3.5 Market Analysis of Synthetic Biology in Spain 2013-2017
2.3.6 Market Analysis of Synthetic Biology in Benelux 2013-2017
2.3.7 Market Analysis of Synthetic Biology in Russia 2013-2017
2.4 Market Development Forecast of Synthetic Biology in Europe 2018-2023
2.4.1 Market Development Forecast of Synthetic Biology in Europe 2018-2023
2.4.2 Market Development Forecast of Synthetic Biology by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Synthetic Biology in Europe by Types
3.1.2 Revenue of Synthetic Biology in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Synthetic Biology in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Synthetic Biology in Europe by Downstream Industry
4.2 Demand Volume of Synthetic Biology by Downstream Industry in Major Countries
4.2.1 Demand Volume of Synthetic Biology by Downstream Industry in Germany
4.2.2 Demand Volume of Synthetic Biology by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Synthetic Biology by Downstream Industry in France
4.2.4 Demand Volume of Synthetic Biology by Downstream Industry in Italy
4.2.5 Demand Volume of Synthetic Biology by Downstream Industry in Spain
4.2.6 Demand Volume of Synthetic Biology by Downstream Industry in Benelux
4.2.7 Demand Volume of Synthetic Biology by Downstream Industry in Russia
4.3 Market Forecast of Synthetic Biology in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF SYNTHETIC BIOLOGY
5.1 Europe Economy Situation and Trend Overview
5.2 Synthetic Biology Downstream Industry Situation and Trend Overview
CHAPTER 6 SYNTHETIC BIOLOGY MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Synthetic Biology in Europe by Major Players
6.2 Revenue of Synthetic Biology in Europe by Major Players
6.3 Basic Information of Synthetic Biology by Major Players
6.3.1 Headquarters Location and Established Time of Synthetic Biology Major Players
6.3.2 Employees and Revenue Level of Synthetic Biology Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 SYNTHETIC BIOLOGY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Amyris
7.1.1 Company profile
7.1.2 Representative Synthetic Biology Product
7.1.3 Synthetic Biology Sales, Revenue, Price and Gross Margin of Amyris
7.2 DuPont
7.2.1 Company profile
7.2.2 Representative Synthetic Biology Product
7.2.3 Synthetic Biology Sales, Revenue, Price and Gross Margin of DuPont
7.3 GenScript USA
7.3.1 Company profile
7.3.2 Representative Synthetic Biology Product
7.3.3 Synthetic Biology Sales, Revenue, Price and Gross Margin of GenScript USA
7.4 Intrexon
7.4.1 Company profile
7.4.2 Representative Synthetic Biology Product
7.4.3 Synthetic Biology Sales, Revenue, Price and Gross Margin of Intrexon
7.5 Integrated DNA Technologies
7.5.1 Company profile
7.5.2 Representative Synthetic Biology Product
7.5.3 Synthetic Biology Sales, Revenue, Price and Gross Margin of Integrated DNA Technologies
7.6 New England Biolabs
7.6.1 Company profile
7.6.2 Representative Synthetic Biology Product
7.6.3 Synthetic Biology Sales, Revenue, Price and Gross Margin of New England Biolabs
7.7 Novozymes
7.7.1 Company profile
7.7.2 Representative Synthetic Biology Product
7.7.3 Synthetic Biology Sales, Revenue, Price and Gross Margin of Novozymes
7.8 Royal DSM
7.8.1 Company profile
7.8.2 Representative Synthetic Biology Product
7.8.3 Synthetic Biology Sales, Revenue, Price and Gross Margin of Royal DSM
7.9 Synthetic Genomics
7.9.1 Company profile
7.9.2 Representative Synthetic Biology Product
7.9.3 Synthetic Biology Sales, Revenue, Price and Gross Margin of Synthetic Genomics
7.10 Thermo Fisher Scientific
7.10.1 Company profile
7.10.2 Representative Synthetic Biology Product
7.10.3 Synthetic Biology Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF SYNTHETIC BIOLOGY
8.1 Industry Chain of Synthetic Biology
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF SYNTHETIC BIOLOGY
9.1 Cost Structure Analysis of Synthetic Biology
9.2 Raw Materials Cost Analysis of Synthetic Biology
9.3 Labor Cost Analysis of Synthetic Biology
9.4 Manufacturing Expenses Analysis of Synthetic Biology
CHAPTER 10 MARKETING STATUS ANALYSIS OF SYNTHETIC BIOLOGY
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Synthetic Biology in This Report
1.2 Commercial Types of Synthetic Biology
1.2.1 Xeno-nucleic Acids
1.2.2 Oligonucleotides
1.2.3 Chassis Organisms
1.2.4 Enzymes
1.2.5 Cloning and Assembly Kits
1.3 Downstream Application of Synthetic Biology
1.3.1 Environmental Application
1.3.2 Medical Application
1.3.3 Industrial Application
1.4 Development History of Synthetic Biology
1.5 Market Status and Trend of Synthetic Biology 2013-2023
1.5.1 Europe Synthetic Biology Market Status and Trend 2013-2023
1.5.2 Regional Synthetic Biology Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Synthetic Biology in Europe 2013-2017
2.2 Consumption Market of Synthetic Biology in Europe by Regions
2.2.1 Consumption Volume of Synthetic Biology in Europe by Regions
2.2.2 Revenue of Synthetic Biology in Europe by Regions
2.3 Market Analysis of Synthetic Biology in Europe by Regions
2.3.1 Market Analysis of Synthetic Biology in Germany 2013-2017
2.3.2 Market Analysis of Synthetic Biology in United Kingdom 2013-2017
2.3.3 Market Analysis of Synthetic Biology in France 2013-2017
2.3.4 Market Analysis of Synthetic Biology in Italy 2013-2017
2.3.5 Market Analysis of Synthetic Biology in Spain 2013-2017
2.3.6 Market Analysis of Synthetic Biology in Benelux 2013-2017
2.3.7 Market Analysis of Synthetic Biology in Russia 2013-2017
2.4 Market Development Forecast of Synthetic Biology in Europe 2018-2023
2.4.1 Market Development Forecast of Synthetic Biology in Europe 2018-2023
2.4.2 Market Development Forecast of Synthetic Biology by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Synthetic Biology in Europe by Types
3.1.2 Revenue of Synthetic Biology in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Synthetic Biology in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Synthetic Biology in Europe by Downstream Industry
4.2 Demand Volume of Synthetic Biology by Downstream Industry in Major Countries
4.2.1 Demand Volume of Synthetic Biology by Downstream Industry in Germany
4.2.2 Demand Volume of Synthetic Biology by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Synthetic Biology by Downstream Industry in France
4.2.4 Demand Volume of Synthetic Biology by Downstream Industry in Italy
4.2.5 Demand Volume of Synthetic Biology by Downstream Industry in Spain
4.2.6 Demand Volume of Synthetic Biology by Downstream Industry in Benelux
4.2.7 Demand Volume of Synthetic Biology by Downstream Industry in Russia
4.3 Market Forecast of Synthetic Biology in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF SYNTHETIC BIOLOGY
5.1 Europe Economy Situation and Trend Overview
5.2 Synthetic Biology Downstream Industry Situation and Trend Overview
CHAPTER 6 SYNTHETIC BIOLOGY MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Synthetic Biology in Europe by Major Players
6.2 Revenue of Synthetic Biology in Europe by Major Players
6.3 Basic Information of Synthetic Biology by Major Players
6.3.1 Headquarters Location and Established Time of Synthetic Biology Major Players
6.3.2 Employees and Revenue Level of Synthetic Biology Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 SYNTHETIC BIOLOGY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Amyris
7.1.1 Company profile
7.1.2 Representative Synthetic Biology Product
7.1.3 Synthetic Biology Sales, Revenue, Price and Gross Margin of Amyris
7.2 DuPont
7.2.1 Company profile
7.2.2 Representative Synthetic Biology Product
7.2.3 Synthetic Biology Sales, Revenue, Price and Gross Margin of DuPont
7.3 GenScript USA
7.3.1 Company profile
7.3.2 Representative Synthetic Biology Product
7.3.3 Synthetic Biology Sales, Revenue, Price and Gross Margin of GenScript USA
7.4 Intrexon
7.4.1 Company profile
7.4.2 Representative Synthetic Biology Product
7.4.3 Synthetic Biology Sales, Revenue, Price and Gross Margin of Intrexon
7.5 Integrated DNA Technologies
7.5.1 Company profile
7.5.2 Representative Synthetic Biology Product
7.5.3 Synthetic Biology Sales, Revenue, Price and Gross Margin of Integrated DNA Technologies
7.6 New England Biolabs
7.6.1 Company profile
7.6.2 Representative Synthetic Biology Product
7.6.3 Synthetic Biology Sales, Revenue, Price and Gross Margin of New England Biolabs
7.7 Novozymes
7.7.1 Company profile
7.7.2 Representative Synthetic Biology Product
7.7.3 Synthetic Biology Sales, Revenue, Price and Gross Margin of Novozymes
7.8 Royal DSM
7.8.1 Company profile
7.8.2 Representative Synthetic Biology Product
7.8.3 Synthetic Biology Sales, Revenue, Price and Gross Margin of Royal DSM
7.9 Synthetic Genomics
7.9.1 Company profile
7.9.2 Representative Synthetic Biology Product
7.9.3 Synthetic Biology Sales, Revenue, Price and Gross Margin of Synthetic Genomics
7.10 Thermo Fisher Scientific
7.10.1 Company profile
7.10.2 Representative Synthetic Biology Product
7.10.3 Synthetic Biology Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF SYNTHETIC BIOLOGY
8.1 Industry Chain of Synthetic Biology
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF SYNTHETIC BIOLOGY
9.1 Cost Structure Analysis of Synthetic Biology
9.2 Raw Materials Cost Analysis of Synthetic Biology
9.3 Labor Cost Analysis of Synthetic Biology
9.4 Manufacturing Expenses Analysis of Synthetic Biology
CHAPTER 10 MARKETING STATUS ANALYSIS OF SYNTHETIC BIOLOGY
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
